This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seewald, S. Articles by Sachinidis, A. Search for Related Content PubMed PubMed Citation Articles by Seewald, S. Articles by Sachinidis, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL

(Hypertension. 1998;31:1151-1156.)
© 1998 American Heart Association, Inc.

Scientific Contributions

Role of Mitogen-Activated Protein Kinase in the Angiotensin II–Induced DNA Synthesis in Vascular Smooth Muscle Cells

Stefan Seewald; Claudia Seul; Ralf Kettenhofen; Dirk Bokemeyer; Yon Ko; Hans Vetter; ; Agapios Sachinidis

From the Medizinische Universitäts-Poliklinik, Bonn, Germany.

Correspondence to Agapios Sachinidis, PhD, Medizinische Universitäts-Poliklinik, Wilhelmstrasse 35-37, 53111 Bonn, Germany. E-mail umm501{at}ibm.rhrz.uni-bonn.de

Abstract—The activation of mitogen-activated protein (MAP) kinase and increase in intracellular free calcium concentration ([Ca²⁺]_i) are discussed in reference to activation of different protein kinases and growth of vascular smooth muscle cells (VSMCs). The aim of the present study was to investigate the role of angiotensin (Ang) II–induced increase in [Ca²⁺]_i for activation of 44-kD/42-kD MAP kinase (p44^mapk/p42^mapk) and DNA synthesis in VSMCs. Experiments were performed by chelation of [Ca²⁺]_i by the intracellular chelator 1,2-bis-(o-amino-5-methylphenoxy)ethane-N,N,N',N'-tetraacetic acid tetraacetoxymethyl ester (MAPTAM). Ca²⁺ was measured by the fura 2 method. MAP kinase activation was determined by the Western blotting method. DNA synthesis was determined by measurement of [³H]thymidine incorporation into the cell DNA. Treatment of VSMCs with 20 µmol/L MAPTAM for 30 minutes resulted in a complete abolishment of the maximal Ang II–induced increase at 10 seconds. Ang II phosphorylated the p44^mapk/p42^mapk in a time-dependent manner, showing a maximum at 3 minutes. In MAPTAM-treated cells, the maximal phosphorylation of MAP kinase isoforms was shifted to 5 minutes, and dephosphorylation was delayed compared with untreated cells. In concordance with this finding, the induction of the MAP kinase phosphatase-1 was markedly impaired in MAPTAM-treated cells. Ang II induced a 2.3-fold increase in [³H]thymidine incorporation into DNA synthesis in untreated cells. This effect was not reduced in MAPTAM-treated cells. Treatment of the cells with PD 98059 (10 µmol/L), a MAP kinase kinase inhibitor, caused 85% inhibition of the Ang II–induced activation of MAP kinases but did not inhibit the Ang II–induced DNA synthesis. In conclusion, the Ang II–induced stimulation of the MAP kinase is a Ca²⁺-dependent process. Furthermore, blockade of the Ang II–induced stimulation of the early intracellular events, such as increase in [Ca²⁺]_i or phosphorylation of the MAP kinase, is not accompanied by an inhibition of the Ang II–induced DNA synthesis.

Key Words: angiotensin II • kinase • calcium • muscle, smooth, vascular

This article has been cited by other articles:

				T. Jinno, M. Iwai, Z. Li, J.-M. Li, H.-W. Liu, T.-X. Cui, H. Rakugi, T. Ogihara, and M. Horiuchi Calcium Channel Blocker Azelnidipine Enhances Vascular Protective Effects of AT1 Receptor Blocker Olmesartan Hypertension, February 1, 2004; 43(2): 263 - 269. [Abstract] [Full Text] [PDF]

				K. Ino, C. Uehara, F. Kikkawa, H. Kajiyama, K. Shibata, T. Suzuki, E. E. Khin, M. Ito, M. Takeuchi, A. Itakura, et al. Enhancement of Aminopeptidase A Expression during Angiotensin II-Induced Choriocarcinoma Cell Proliferation through AT1 Receptor Involving Protein Kinase C- and Mitogen-Activated Protein Kinase-Dependent Signaling Pathway J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3973 - 3982. [Abstract] [Full Text] [PDF]

				R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF]

				M. M. Muthalif, I. F. Benter, Z. Khandekar, L. Gaber, A. Estes, S. Malik, J.-H. Parmentier, V. Manne, and K. U. Malik Contribution of Ras GTPase/MAP Kinase and Cytochrome P450 Metabolites to Deoxycorticosterone-Salt-Induced Hypertension Hypertension, January 1, 2000; 35(1): 457 - 463. [Abstract] [Full Text] [PDF]

				S. K. Sharma, P. Zahradka, D. Chapman, H. Kumamoto, N. Takeda, and N. S. Dhalla Inhibition of Serotonin-Induced Vascular Smooth Muscle Cell Proliferation by Sarpogrelate J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1475 - 1481. [Abstract] [Full Text]

				K. Tamura, N. Nyui, N. Tamura, T. Fujita, M. Kihara, Y. Toya, I. Takasaki, N. Takagi, M. Ishii, K.-i. Oda, et al. Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells J. Biol. Chem., October 9, 1998; 273(41): 26487 - 26496. [Abstract] [Full Text] [PDF]